Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review

Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review

The management of advanced gastric cancer has improved over the past decade. There is more evidence to support the efficacy of systemic treatment in refractory gastric cancer beyond second-line treatment. Important randomized controlled trials of chemotherapies, targeted agents and immunotherapies h...

Full description

Bibliographic Details
Main Authors:	Wing-lok Chan, Ka-on Lam, Tsz-him So, Victor Ho-fun Lee, Lai-wan Dora Kwong
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-06-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758835919859990

Similar Items

Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
by: Sik-Kwan Chan, et al.
Published: (2020-08-01)

Local and systemic treatment for HER2-positive breast cancer with brain metastases: a comprehensive review
by: Wing-Lok Chan, et al.
Published: (2020-09-01)

Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done
by: Marzia Mare, et al.
Published: (2022-09-01)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
by: Horace Cheuk-Wai Choi, et al.
Published: (2021-02-01)

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
by: Kin-Sang Lau, et al.
Published: (2021-11-01)

ARHGAP15 promotes metastatic colonization in gastric cancer by suppressing RAC1-ROS pathway.
by: Fei-Fei Zhang, et al.
Published: (2023-02-01)

Role of Systemic Treatment for Advanced/Metastatic Gastric Carcinoma in the Third-Line Setting: A Bayesian Network Analysis
by: Wen-Tao Pan, et al.
Published: (2020-04-01)

Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA
by: Afsaneh Barzi, et al.
Published: (2023-08-01)

Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma
by: Ka Hey Agnes Fong, et al.
Published: (2025-02-01)

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
by: In Sil Choi, et al.
Published: (2018-01-01)

Clinical Study of Anlotinib as Third-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Multicenter Retrospective Study
by: Caiyun Nie, et al.
Published: (2022-07-01)

Spatial epidemiological approaches in disease mapping and analysis /
by: 358371 Lai, Poh-Chin, et al.
Published: (2009)

Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
by: Moe, M, et al.
Published: (2008)

Chemotherapy options for metastatic colorectal carcinoma: First, second, third line...
by: Tomašević Zorica I., et al.
Published: (2003-01-01)

Late-line treatment in metastatic gastric cancer: today and tomorrow
by: Elizabeth C. Smyth, et al.
Published: (2019-08-01)

A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer
by: Nuoya Yu, et al.
Published: (2024-02-01)

Successful Remission of Hemolytic-Uremic Syndrome during the Third-line Weekly Gemcitabine for Metastatic Breast Cancer
by: Victor C. Kok, et al.
Published: (2014-01-01)

Successful Remission of Hemolytic-Uremic Syndrome During the Third-line Weekly Gemcitabine for Metastatic Breast Cancer
by: Victor C. Kok, et al.
Published: (2014-03-01)

Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers
by: Wing-Lok Chan, et al.
Published: (2014-01-01)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
by: Tsz Him So, FRCR, et al.
Published: (2020-09-01)

Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate
by: Wing-Lok Chan, et al.
Published: (2021-07-01)

Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma
by: Lanqi Gong, et al.
Published: (2021-03-01)

Electroacupuncture Plus Auricular Acupressure on Chemotherapy-Related Insomnia in Patients With Breast Cancer (EACRI): Study Protocol for a Randomized, Sham-Controlled Trial
by: Jialing Zhang, et al.
Published: (2021-11-01)

A real-world study: third-line treatment options for metastatic colorectal cancer
by: Chen Wu, et al.
Published: (2024-12-01)

Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
by: Michela Roberto, et al.
Published: (2015-01-01)

Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency
by: R. T. Ayupov, et al.
Published: (2021-12-01)

Mesoporous Zn/MgO Hexagonal Nano-Plates as a Catalyst for <i>Camelina</i> Oil Biodiesel Synthesis
by: Lai-Fan Man, et al.
Published: (2021-10-01)

Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancer
by: P Bohanes, et al.
Published: (2011-08-01)

PD-1 inhibitors-based second-line therapy for metastatic gastric cancer
by: Miaomiao Gou, et al.
Published: (2023-05-01)

A Cost-Effectiveness Analysis of Systemic Therapy for Metastatic Hormone-Sensitive Prostate Cancer
by: Winnie W. Y. Sung, et al.
Published: (2021-02-01)

Comparison of the efficacy and safety of third-line treatments for advanced gastric cancer: A systematic review and network meta-analysis
by: Chan Zhang, et al.
Published: (2023-03-01)

New drug developments in metastatic gastric cancer
by: Aaron C. Tan, et al.
Published: (2018-11-01)

Efficacy and safety of third-line or later-line targeted treatment for patients with metastatic colorectal cancer: a meta-analysis
by: Wen-Hui Xue, et al.
Published: (2023-05-01)

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
by: Carmine Pinto, et al.
Published: (2025-01-01)

Isolated Limb Infusion as First, Second, or Third or Later-Line Therapy for Metastatic In-Transit Melanoma
by: Aleena Boby BA, et al.
Published: (2024-10-01)

Third-line treatment options in metastatic pancreatic cancer patients: a real-world study
by: Hong-Rui Lu, et al.
Published: (2023-09-01)

Cost-Effectiveness Analysis of Regorafenib versus Other Third-Line Treatments for Metastatic Colorectal Cancer
by: Zhong J, et al.
Published: (2024-06-01)

A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer
by: Aya El Helali, et al.
Published: (2022-10-01)

Return to Work and Work Productivity During the First Year After Cancer Treatment
by: Serana Chun Yee So, et al.
Published: (2022-04-01)

The full management from first-line to third-line treatments in patients with Her-2–negative advanced gastric cancer
by: Chunxiao Chang, et al.
Published: (2022-11-01)